Back to Search Start Over

A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery.

Authors :
Okabayashi, Shihoko
Ogawa, Satoru
Tanaka, Kenichi A.
Nishiyama, Takashi
Takeshita, Shusuke
Nakayama, Yoshinobu
Nakajima, Yasufumi
Sawa, Teiji
Mizobe, Toshiki
Source :
Journal of Cardiothoracic & Vascular Anesthesia; Aug2018, Vol. 32 Issue 4, p1609-1614, 6p
Publication Year :
2018

Abstract

Objective Point-of-care (POC) devices allow for prothrombin time/international normalized ratio (PT/INR) testing in whole blood (WB) and timely administration of plasma or prothrombin complex concentrate during cardiopulmonary bypass surgery. This study evaluated the sensitivities of a new POC PT test, a dry-hematology method with heparin neutralization technology (DRIHEMATO PT-S [DRI PT-S]; A&T Corporation, Kanagawa, Japan), and compared it with other POC tests currently available. Design Prospective, observational study. Setting University hospital, single center. Participants Healthy volunteers and warfarin-treated and cardiac surgical patients. Measurement and Main Results In WB samples obtained from 6 healthy volunteers, PT-INR results of DRI PT-S were not affected by an in vitro addition of heparin <6.0 U/mL. In warfarin-treated samples (n = 88, PT/INR 0.98-3.87), PT-INR with DRI PT-S showed acceptable correlation with the laboratory method ( r 2 = 0.85, p < 0.001). In blood samples obtained from cardiac surgical patients (n = 72), heparin prolonged the PT/INR with the laboratory assay, dry-hematology method with non heparin neutralization technology (DRI PT), Coaguchek XS (Roche Diagnostics, Basel, Switzerland), and Hemochron Jr. (Accriva Diagnostics, Edison, NJ), but DRI PT-S was not affected by heparin anticoagulation. In nonheparinized samples, different methods between DRI PT-S and the laboratory method yielded acceptable correlations ( r 2 = 0.76, p < 0.0001). There was a moderate correlation between factor levels and the PT-INR with DRI PT-S (factor [F]II: r 2 = 0.63, FVII: r 2 = 0.47, FX: r 2 = 0.67; p < 0.0001). Conclusions This study demonstrated that PT/INR can be accurately assessed using the dry-hematology method in WB under therapeutic heparin levels. Currently available other POC PT/INR tests are affected by heparin, and thus they are not recommended for coagulation monitoring during cardiopulmonary bypass. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10530770
Volume :
32
Issue :
4
Database :
Supplemental Index
Journal :
Journal of Cardiothoracic & Vascular Anesthesia
Publication Type :
Academic Journal
Accession number :
130949013
Full Text :
https://doi.org/10.1053/j.jvca.2017.12.044